Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to determine performance characteristics of the FebriDx test in predicting viral or bacterial infection etiology among febrile (observed or reported) patients presenting the emergency department, urgent care centers or primary care offices with suspected acute respiratory tract infection.


Clinical Trial Description

This is a prospective, multi-center, observational, blinded clinical trial whereby consented study subjects will be enrolled into two study cohorts: an Acute Respiratory Infection cohort and an Asymptomatic cohort. Subjects (children/adolescents, adults and elderly) with suspected community acquired Acute Respiratory Infection will be enrolled in the Acute Respiratory Infection cohort and subjects without infectious illness will be enrolled in the Asymptomatic cohort. All subjects will undergo FebriDx testing (study device) and results, blinded to subjects and treating physicians, will be compared to a Clinical Reference Algorithm supervised by clinical experts to arbitrate the presence and type of infection (bacterial or viral); the experts are also blinded to the results of FebriDx testing. The FebriDx® test is a rapid, point-of-care (POC) test that uses a fingerstick blood sample to identify patients with a pathogen induced host immune response through in-vitro detection of both Myxovirus resistance protein A (MxA) and c-reactive protein (CRP) directly from a whole blood sample. MxA is an intracellular protein that becomes elevated in the presence of acute viral infection and CRP is an acute-phase inflammatory protein that is elevated in the presence of a systemic bacterial and/or viral infection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02018198
Study type Observational
Source Lumos Diagnostics
Contact
Status Completed
Phase
Start date October 15, 2019
Completion date June 10, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05929599 - Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections N/A
Completed NCT05166369 - Optimisation of Antibiotic Prescription in Acute Noncomplicated Respiratory Tract Infections in Children (OptimAP Study) N/A
Completed NCT00989482 - Improving Antibiotic Prescribing Practices in Mexican Primary Care Clinics N/A
Completed NCT02473796 - Home Based Child Care to Reduce Mortality and Malnutrition in Tribal Children of Melghat, India: CRCT N/A
Completed NCT02046577 - Study of Vitamin D for the Prevention of Acute Respiratory Infections in Children Phase 2
Completed NCT05378022 - Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children N/A
Completed NCT05164692 - Effects of Nasal-spraying LiveSpo Navax in Treatment of Acute Respiratory Infections in Children N/A